Frequently asked
questions
We will be adding to the Frequently Asked Questions over time. Please drop us a note with any questions about the support we provide, application process or how you can get involved. Please also sign-up on our contact page:
Contact Us
The INCATE portfolio is here – Portfolio
As new companies are selected they will be added here
No, you can be based anywhere in the world.
Your application should contain non-confidential material until we ask you for Confidential material under an NDA. The material provided is shared with the INCATE Selection Committee and their representatives, where necessary a bilateral NDA between your entity and INCATE including consultants and select members of the INCATE Selection Committee can be made.
Please contact a member of the INCATE Management Committee. Contact page here
No. We can connect you to opportunities for these where necessary.
INCATE does not provide follow up funding but we connect you to a community of investors, industry partners and supporting partners who can continue to support you once you have built an investable case along with INCATE.
We would ask you to provide some basic information and then have a short meeting with you to understand your needs and confirm that you are ready to submit a full application. In this meeting we would identify some key questions that we suggest you begin to work on.
We would then invite you to fill in a Stage I application that would include detail of how we would support you in Stage I. After selection in Stage I we would work with you according to the plan suggested along with any adaption post the Selection Committee. This includes work for you to do and some sponsored support such as regulatory strategy, safety study etc.
We would spend time with you during Stage I to develop a pitch deck and plan that would form the basis of your application to Stage II.
Stage II – this again would be work according to the plan suggested along with any adaption post the Selection Committee but now with an increased budget.
That is great and what we are all working towards. You can choose to continue to work with INCATE but funding from INCATE may no longer be relevant.
No. The advice and funding is provided at no-cost and with no dilution.
No. We hope that you are able to find a fruitful collaboration with Partners in our network but there is no obligation to do so.
We hope you continue to support INCATE post the program as part of the community. There is no obligation to give back. As the business model for Antibiotics is fixed and the reward for Antibiotic innovators increase in coming years we hope that you would re-invest in the next generation of Antibiotics.
We hope that during Stage II you are able to produce enough evidence to get support from other members of the ecosystem supporting the fight against drug-resistant bacterial infections such as the Industry Partners in the INCATE Selection Committee, Carb-X, GARDP, non-dilutive funding or equity investment.
We try and support all early stage innovators with advice from INCATE management and access to our community and events. As part of this we help you prepare an application to the INCATE Selection Committee for acceptance in to Stage I. We may also give you the feedback at this stage that you are not ready for Stage I and why.
Stage I – The INCATE Selection Committee selects projects to be selected into Stage I. We may also invite you to discuss your venture in more detail with the INCATE Selection Committee or their representatives. We will publish a more detailed criteria over time but this is likely to include; Medical need targeted, innovation potential, likelihood of equitable access, team (a weak team is not a killer at Stage I but you need to build it!), Likelihood to develop a case for significant investment case within 24 months and our ability to help
Stage II – The committee will decide which ventures are taken into Stage II and the amount of funding based on the above criteria plus progress made.
We do not support educational projects, late stage products or basic research.
INCATE is for innovators fighting drug-resistant bacterial infections with new therapies, development platforms, diagnostics, digital tools and supporting technologies.
We want to help you to build investable projects and companies that are ready for the next level of investment from Industry, targeted funds like Carb-X or Novo Repair fund, traditional investors and in some cases further non-dilutive funding.
As of Q1 2022 our focus is on therapies and we are investigating how we can help with diagnostics and devices. Digital tools are not likely to be considered until late 2022 at the earliest (unless you wow us).
To give you an idea of approximate stage, we think we can help most in the following space;
- Drug projects with initial proof of concept and hit/lead identified- (TRL 2-4)
Diagnostic projects that have a POC (TRL 3-4)
Digital tools and other technologies that have a POC from one setting, though the nature of these innovations means it may be harder to set a clear boundary(TRL 3-5)
If you aren’t sure please contact us.
INCATE is a unique partnership for academic and industry participants that can help your innovation progress. We support innovators by providing advice from Industry Partners during and after the selection process, individualised coaching and from translational academic partners and support institutions. We also connect you to a community of other innovators plus those partners such as investors whom you will need in your entreprenuerial journey. We also provide Non-Dilutive funding that can help you answer key questions. We believe that this package will help you move faster to becoming investible if your venture should progress and help you to make the difficult choice of stopping if this particular approach is not likely to succeed.
